FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

8941001000001100: Not available (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40299001000001111 Not available (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40299101000001112 Not available en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Not available Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline 30 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline 10 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely nefazodone hydrochloride 100 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely nefazodone hydrochloride 200 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Nefazodone hydrochloride 50mg+100mg+200mg initiation tablet pack VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely metoclopramide hydrochloride 5 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely prochlorperazine mesilate 5 milligram/1 sachet conventional release effervescent oral granules (clinical drug) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely prochlorperazine maleate 25 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely prochlorperazine maleate 5 milligram/1 each conventional release rectal suppository VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely prochlorperazine maleate 25 milligram/1 each conventional release rectal suppository VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely cisapride 10 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Granisetron 200micrograms/mL pediatric liquid VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 100 milligram/1 milliliter conventional release oral solution VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Nefopam hydrochloride 20mg/mL injection solution 1mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely codeine phosphate 60 milligram and paracetamol 1 gram/1 sachet effervescent powder for conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely morphine hydrochloride 15 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Opium 10mg/mL tincture VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely dextromoramide 5 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely dextromoramide 10 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Nalbuphine hydrochloride 10mg/mL injection solution 1mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Nalbuphine hydrochloride 10mg/mL injection solution 2mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely pentazocine (as pentazocine lactate) 50 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely tramadol hydrochloride 50 milligram/1 sachet effervescent powder for conventional release oral solution VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely tramadol hydrochloride 100 milligram/1 sachet effervescent powder for conventional release oral solution VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Tramadol hydrochloride 75mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Morphine sulfate 20mg m/r capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Morphine sulfate 50mg m/r capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely levodopa 500 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Pergolide 50micrograms tablet and pergolide 250micrograms tablet starter pack VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely biperiden hydrochloride 2 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cefazolin (as cefazolin sodium) 1 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely cefpirome (as cefpirome sulfate) 1 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cefprozil 250 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cefprozil 500 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cefprozil 50 milligram/1 milliliter conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely tetracycline 250 milligram/1 each conventional release oral capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Gentamicin 10mg/mL injection solution 2mL vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Netilmicin 100mg/mL injection solution 2mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Netilmicin 10mg/mL injection solution 1.5mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Netilmicin 50mg/mL injection solution 1mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Netilmicin 100mg/mL injection solution 1mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Netilmicin 100mg/mL injection solution 1.5mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Tobramycin 10mg/mL injection solution 2mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Tobramycin 40mg/mL injection solution 1mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Tobramycin 40mg/mL injection solution 2mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Sulfadiazine 1g/4mL injection VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trimethoprim 20mg/mL injection solution 5mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely pyrazinamide 500 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely clofazimine 100 milligram/1 each conventional release oral capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Metronidazole+nystatin 400mg/10000units tablet+pessary VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely nalidixic acid 500 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Nalidixic acid+sodium citrate 660mg/sachet effervescent granules VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5mL s/f suspension VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Ciprofloxacin 2mg/mL infusion solution 200mL bottle VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Ofloxacin 2mg/mL infusion solution 50mL vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely amphotericin 100 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Amphotericin 100mg/mL s/f suspension VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely ganciclovir 250 milligram/1 each conventional release oral capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely ganciclovir 500 milligram/1 each conventional release oral capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely zalcitabine 750 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely saquinavir 200 milligram/1 each conventional release oral capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely indinavir (as indinavir sulfate) 333 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Insulin zinc extended release 100units/mL injection 10mL vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely guar gum 5 gram/1 sachet granules for conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely prednisolone 50 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely estradiol 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Hydroxyprogesterone caproate 250mg/mL injection ampule 1mL VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely progesterone 40 milligram/1 gram conventional release vaginal gel (clinical drug) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Testosterone 6mg/24hours transdermal patch VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely stanozolol 5 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Choriogonadotropin alfa 2000iu powder and solvent for injection solution ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Choriogonadotropin alfa 10,000iu powder and solvent for injection solution ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Recombinant human follicle stimulating hormone alpha 37.5iu powder and solvent for injection solution ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Urofollitropin 75iu powder and solvent for injection solution ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Somatropin(rbe) 4iu(1.33mg) powder and solvent for injection solution vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Sermorelin 50micrograms powder and solvent for injection solution ampules VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely ergometrine maleate 500 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Stilbestrol+lactic acid 500micrograms/5% pessary VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Povidone-iodine 10% vaginal gel VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 50 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely nonoxinol 125 milligram/1 gram conventional release vaginal foam VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely nonoxinol 20 milligram/1 milliliter conventional release vaginal gel VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely mandelic acid 10 milligram/1 milliliter conventional release solution for irrigation (clinical drug) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Mustine hydrochloride 10mg injection VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Vinblastine sulfate 10mg injection (pdr for recon)+diluent VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely razoxane 125 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier

Start Previous Page 73 of 304 Next End


This concept is not in any reference sets

Back to Start